SCHEMBL6898653

SCHEMBL6898653

CC(C)CC(CN)CP(=O)(O)O.NCC1(CP(=O)(O)O)CCCCC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA2D1 P54289 3/20 0.34
LMNA P02545 2/20 0.34
CYP1A2 P05177 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
CACNB3 P54284 1/20 0.34
CACNA1C Q13936 1/20 0.34
PGR P06401 1/20 0.34
ADRA1A P35348 1/20 0.34
HTR2B P41595 1/20 0.34
CACNA2D2 Q9NY47 1/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34
BLM P54132 1/20 0.34
ANPEP P15144 3/20 0.33
LAP3 P28838 2/20 0.33
ERAP1 Q9NZ08 1/20 0.33
GABBR2 O75899 1/20 0.31
GABBR1 Q9UBS5 1/20 0.31
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5388073 0.79 TSHR (0.50) CACNA2D1LMNACYP1A2SMN1; SMN2USP2
SCHEMBL5381361 0.79 ANPEP (0.50) CACNA2D1LMNACYP1A2SMN1; SMN2CACNB3
SCHEMBL5394737 0.79 TSHR (0.50) CACNA2D1LMNACYP1A2SMN1; SMN2USP2
SCHEMBL5394762 0.77 TSHR (0.47) CACNA2D1LMNACYP1A2SMN1; SMN2USP2
Gabapentin SCHEMBL876152 0.69 CACNA2D1 (0.61) CACNA2D1LMNACYP1A2SMN1; SMN2CACNB3
SCHEMBL7429556 0.68 CYP1A2 (0.46) CACNA2D1LMNACYP1A2SMN1; SMN2USP2
SCHEMBL7429551 0.68 CYP1A2 (0.46) CACNA2D1LMNACYP1A2SMN1; SMN2USP2
SCHEMBL7255156 0.65 USP2 (0.33) CACNA2D1LMNACYP1A2SMN1; SMN2USP2
SCHEMBL7429187 0.64 USP2 (0.33) CACNA2D1LMNACYP1A2SMN1; SMN2USP2
SCHEMBL5386048 0.64 ALDH1A1 (0.31) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1047678-B1 1-SUBSTITUTED-1-AMINOMETHYL-CYCLOALKANE DERIVATIVES (=GABAPENTIN ANALOGUES), THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS WARNER LAMBERT CO (US) 2004-09-08 EP claimed